Navigation Links
Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
Date:8/12/2008

nomodulators, particularly Diamyd Medical's DiamydT and DeveloGen/Andromeda Biotech's DiaPep-277, will drive growth in the Type 1 diabetes market. Through 2017, sales of DiamydT and DiaPep-277 will reach $45 million.

"Experts that we interviewed unanimously agree that the treatment of type 1 diabetes is characterized by a high level of unmet need for therapies that can halt the destruction of insulin-producing pancreatic-beta cells," said Caroline Gates, analyst at Decision Resources. "Immunomodulators have the potential to preserve beta-cell function, but their use will be hampered by long-term safety concerns, high prices and by the small number of eligible patients who would benefit from these agents."

About Decision Resources

Decision Resources (http://www.decisionresources.com) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources, Inc.

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
2. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
3. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
4. Treatment Corrects Severe Insulin Imbalance in Animal Studies
5. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
6. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
7. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
8. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
9. Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin
10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
11. Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/rt3mhz/deciphering ... "Deciphering Global Major Pharmaceutical Companies, New Outsourcing Demands ... It has been publicly recognized that global ... series of challenges in the recent years. The ... in small molecule product manufacturing; increasingly challenging process ...
(Date:7/7/2015)... 7, 2015   Decision Resources Group ... dialysis patient management in the U.S. versus the ... U.S. and EU5 nephrologists from approximately 1,870 dialysis ... the most commonly used renal medications in dialysis ... considerably between the two regions.      Other ...
(Date:7/7/2015)... BANGALORE , July 7, 2015 ... innovative clinical trial data management solutions, has been featured ... publication named " EDC and eCOA / ePRO Market ... is one of the leading providers of research and ... 22 EDC and eCOA / ePRO tools in the ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... Minimally Invasive Surgery Symposium (MISS) will include discussion of ... surgery, single-port bariatric surgery, transoral gastroplasty, and other "frontier" ... by MISS Executive Director Philip R Schauer, MD, on ... , The five-day CME conference, which will be held ...
... Oct. 27 Endologix, Inc. (Nasdaq: ... disorders, today announced financial results for the three and ... McDermott, Endologix President and Chief Executive Officer, said, "Our ... sales of new products by our domestic sales force ...
Cached Medicine Technology:Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 2Endologix Reports 47% Third Quarter 2009 Revenue Growth 2Endologix Reports 47% Third Quarter 2009 Revenue Growth 3Endologix Reports 47% Third Quarter 2009 Revenue Growth 4Endologix Reports 47% Third Quarter 2009 Revenue Growth 5Endologix Reports 47% Third Quarter 2009 Revenue Growth 6Endologix Reports 47% Third Quarter 2009 Revenue Growth 7Endologix Reports 47% Third Quarter 2009 Revenue Growth 8
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, the leading ... CelestixFederated VA Series virtual appliances. These virtual platforms expand the existing physical ... have proven to simplify the on-premises deployment of unified remote access and single ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... and development solutions for drugs, biologics and consumer health products, today announced ... access its antibody combination therapy (ACT) technology platform. The platform has the ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation (IDF) ... community using its IDF ePHR, an electronic personal health record powered by Get ... easily track their health information, including symptoms, diagnoses, medications, infusions and other critical ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... Detroit was the site of the National Baptist Convention 110th Annual Session of ... encouraging and promoting the collaboration of churches and their congregations, medical professionals and ...
(Date:7/7/2015)... ... July 07, 2015 , ... Dr. Poneh Ghasri , ... treatments. A professional teeth whitening is one of the fastest, easiest ways to brighten ... they can decrease smile satisfaction and confidence. With the right teeth whitening treatment, patients ...
Breaking Medicine News(10 mins):Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3
... after surgery eases concern over side effects, study finds ... counseling appears to benefit men who have all or ... early-stage prostate cancer, says a U.S. study. , ... receive one of the following: two 60- to 90-minute ...
... Corporation of America (Nasdaq: DCAI ) announced ... with the University of Cincinnati , College of ... the next three years, will be used solely to ... kidney disease. This multi-year agreement gives Dialysis Corporation of ...
... teach my body to stop craving food? How can I ... of anesthesia? Can long-term use of Fosamax actually increase risk ... medical experts and authors answer all your questions at the ... by Fox 5 medical reporter Dr. Sapna Parikh. The event ...
... legislators brainstorm ways to reduce significant levels of ... continues to find innovative solutions to educate the ... abuse. Innocorp President Michael Aguilar announced today that ... Mr. Glynn Birch, has been named as Innocorp,s ...
... being phased out, experts note, , , WEDNESDAY, April 8 ... are found in a wide range of products, and ... not boost risks for a range of malignancies ... chemicals, perfluorooctanoate and perfluorooctanesulfonate (PFOA, PFOS) have for decades ...
... New Yorkers have elevated levels of cotinine in their ... toxic second-hand smoke in concentrations high enough to leave ... breakdown, is not harmful itself but signals exposure to ... this week in the journal Nicotine and Tobacco ...
Cached Medicine News:Health News:Stress Management Battles Prostate Cancer Anxiety 2Health News:Dialysis Corporation of America Announces Establishment of Clinical Grant Agreement with the University of Cincinnati, College of Medicine 2Health News:Best-selling authors and physicians from NYP/Weill Cornell discuss diet, surgery and bone health 2Health News:Former MADD National President Joins Innocorp, ltd. 2Health News:Common Industrial Chemicals May Not Boost Cancer Risk 2Health News:Common Industrial Chemicals May Not Boost Cancer Risk 3Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 2Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 3Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 4
... The Stabilizing Ankle support features ... which lock the calcaneus into ... eversion and inversion. The full-circumference ... and stability. Ideal for chronic ...
... Wee Walker Pediatric Boot is ... pediatric boot that offers superior ... Only two sizes are offered ... sizes will fit left or ...
... Boot is designed as a flexible ... the mid-tibia or fibula to mid-foot ... support. The Bledsoe EZ Set PTB ... motion from 20 degrees of dorsi-flexion ...
... as a flexible and attractive alternative to casting ... and also for second and third degree ankle ... Bledsoe Hi-Top Boot but offers similar support. The ... range of motion from 20 degrees of dorsi-flexion ...
Medicine Products: